EUROLAB
iso-10993-16-toxicokinetic-study-protocol
Biocompatibility Testing ASTM F1609 Evaluation of Surface ContaminationASTM F1904 Protein Adsorption TestingASTM F1980 Accelerated Aging of Medical DevicesASTM F2027 Cytotoxicity EvaluationASTM F2028 Evaluation of Sterilization ResidualsASTM F2052 Magnetically Induced DisplacementASTM F2080 Durability TestingASTM F2095 Evaluation of Additives in Medical PolymersASTM F2096 Particulate TestingASTM F2100 Medical Mask TestingASTM F2130 Endotoxin TestingASTM F2149 Antimicrobial Activity TestingASTM F2180 Sterilization Validation for HydrogelsASTM F2182 RF Induced Heating TestsASTM F2213 Evaluation of Magnetic Resonance CompatibilityASTM F2255 Acute Systemic ToxicityASTM F2273 Cytokine AnalysisASTM F2392 Implant Wear Debris AnalysisASTM F2458 Biofilm Formation TestingASTM F2459 Adhesion of Medical Device CoatingsASTM F2478 Safety Evaluation of PolymersASTM F2503 MR Safety LabelingASTM F2900 Testing of BiopolymersASTM F2941 Shelf Life TestingASTM F640 Extraction of Medical DevicesASTM F748 Evaluation of Medical Device BiocompatibilityASTM F756 Assessment of Hemolytic PropertiesEN ISO 10993-1 Biological Evaluation – Part 1EN ISO 10993-10 Sensitization TestingEN ISO 10993-11 Systemic ToxicityEN ISO 10993-5 Cytotoxicity TestingIEC 60601-1 Safety Requirements for Medical Electrical EquipmentISO 10993-1 Biological Evaluation of Medical DevicesISO 10993-10 Sensitization TestingISO 10993-11 Systemic Toxicity TestingISO 10993-12 Sample Preparation and Reference MaterialsISO 10993-13 Identification and Quantification of Degradation ProductsISO 10993-14 Degradation TestingISO 10993-15 Toxicokinetic StudyISO 10993-17 Establishing Allowable LimitsISO 10993-18 Chemical Characterization TechniquesISO 10993-19 Biodegradation TestingISO 10993-2 Animal Welfare RequirementsISO 10993-20 Toxicology Data AnalysisISO 10993-21 Evaluation of Metals and AlloysISO 10993-22 Irradiation of Medical DevicesISO 10993-23 Biological Evaluation of ResidualsISO 10993-24 Toxicological Risk AssessmentISO 10993-25 Genotoxicity in Medical DevicesISO 10993-26 Immunotoxicology TestingISO 10993-27 Implant Material CharacterizationISO 10993-28 Evaluation of Metallic ImplantsISO 10993-29 Extraction ConditionsISO 10993-3 Genotoxicity TestingISO 10993-30 Analytical TechniquesISO 10993-31 Mutagenicity TestingISO 10993-32 Toxicity Tests for Medical PolymersISO 10993-33 Biological Evaluation of Degradation ProductsISO 10993-34 Evaluation of Chemical ResiduesISO 10993-35 Assessment of Extractables and LeachablesISO 10993-36 Nonclinical Safety EvaluationISO 10993-37 Evaluation of Cytokine ReleaseISO 10993-38 Endocrine Disruption TestingISO 10993-39 Evaluation of Material ExtractsISO 10993-4 Hemocompatibility TestingISO 10993-40 Evaluation of HemocompatibilityISO 10993-41 Toxicological Risk Assessment FrameworkISO 10993-42 Assessment of NanomaterialsISO 10993-5 Cytotoxicity TestingISO 10993-6 Local Effects after ImplantationISO 10993-7 Ethylene Oxide ResidualsISO 10993-9 Chemical CharacterizationISO 11135 Ethylene Oxide SterilizationISO 11137 Radiation SterilizationISO 11607 Packaging for Terminally Sterilized DevicesISO 11607-1 Packaging ValidationISO 11607-2 Packaging MaterialsISO 11607-3 Packaging TestingISO 11737-1 Sterilization ValidationISO 11737-2 Microbial Limit TestsISO 11737-3 Bioburden DeterminationISO 13408 Aseptic ProcessingISO 13408-1 Cleanroom TestingISO 13408-2 Aseptic Processing ValidationISO 13485 Quality Management Systems for Medical DevicesISO 13485 Risk Management IntegrationISO 13485-1 Quality System RequirementsISO 14117 Pulse Oximeter PerformanceISO 14155 Clinical Investigation StandardsISO 14155-1 Clinical Trial DesignISO 14155-2 Clinical Trial ConductISO 14160 Biocompatibility for Transfusion EquipmentISO 14161 Sterilization by Ethylene OxideISO 14161 Validation of Sterilization ProcessesISO 14630 Non-active Surgical ImplantsISO 14644 Cleanroom StandardsISO 14708 Active Implantable Medical DevicesISO 14708-3 Active Implantable Device TestingISO 14708-4 Implantable Device SafetyISO 14969 Quality Management for Sterile DevicesISO 14971 Risk Management DocumentationISO 14971 Risk Management for Medical DevicesISO 14971-2 Risk Management ReportingISO 15223 Medical Device SymbolsISO 17025 Testing Laboratory AccreditationISO 18113 Medical Device LabelingISO 18562 Biocompatibility of Breathing Gas PathwaysISO 22442 Medical Device Material TestingISO 25539 Cardiovascular ImplantsISO 25539-2 Coronary StentsISO 7405 Evaluation of Biocompatibility for DentistryISO 80369 Small-Bore ConnectorsUSP <87> Biological Reactivity TestsUSP <88> Tests for Plastic Materials

Comprehensive Guide to ISO 10993-16 Toxicokinetic Study Protocol Laboratory Testing Service Provided by Eurolab

ISO 10993-16 is a standard developed by the International Organization for Standardization (ISO) that outlines the requirements for toxicokinetic study protocols. This standard is part of the ISO 10993 series, which provides guidance on the biological evaluation of medical devices.

Relevant Standards

The following standards are relevant to ISO 10993-16:

  • ISO 10993-1:2018 Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process

  • ISO 10993-2:2016 Biological evaluation of medical devices - Part 2: Animal welfare requirements

  • ASTM F1980-14 Standard Guide for Characterization of Particulates in Inhaled Air

    • Legal and Regulatory Framework

    The legal and regulatory framework surrounding ISO 10993-16 is governed by various national and international regulations. These include:

  • EU Medical Device Regulation (MDR) 2017/745

  • US FDA Guidance for Industry: Use of International Standard ISO 10993-1

  • Canadas Medical Devices Regulations

    • International and National Standards

    ISO 10993-16 is an international standard that has been adopted by various countries. Some notable national standards include:

  • ASTM F1980-14 (USA)

  • EN ISO 10993-16:2015 (EU)

  • TSE ISO 10993-16:2020 (Turkey)

    • Standard Development Organizations

    The following organizations play a crucial role in the development and maintenance of standards related to ISO 10993-16:

  • International Organization for Standardization (ISO)

  • American Society for Testing and Materials (ASTM)

  • European Committee for Standardization (CEN)

  • Turkish Standards Institution (TSE)

    • Standard Evolution and Update

    Standards evolve over time as new technologies, research findings, and regulatory requirements emerge. The ISO 10993 series is regularly reviewed and updated to ensure it remains relevant and effective.

    Standard Numbers and Scope

    The following standard numbers are related to ISO 10993-16:

  • ISO 10993-1:2018

  • ISO 10993-2:2016

  • ISO 10993-16:2020

    • These standards provide guidance on the evaluation and testing of medical devices, including toxicokinetic study protocols.

    Standard Compliance Requirements

    Compliance with standard requirements is crucial for industries that develop and market medical devices. Failure to comply can result in regulatory non-compliance, product recalls, and damage to reputation.

    Industries and Sectors

    The following industries and sectors require ISO 10993-16 testing:

  • Medical device manufacturers

  • Biotechnology companies

  • Pharmaceutical industry

  • Research institutions

    • These organizations must ensure their products meet the necessary safety and performance requirements.

    Risk Factors and Safety Implications

    Failure to perform toxicokinetic study protocols can result in adverse health effects, product recalls, and regulatory non-compliance. The risk factors associated with ISO 10993-16 testing include:

  • Inadequate evaluation of toxicological data

  • Failure to identify potential hazards

  • Insufficient testing procedures

    • Quality Assurance and Quality Control

    ISO 10993-16 requires organizations to implement quality assurance and quality control measures to ensure the accuracy and reliability of test results.

    Contribution to Product Safety and Reliability

    The ISO 10993 series, including ISO 10993-16, contributes significantly to product safety and reliability by providing a framework for evaluating medical devices. This ensures that products meet regulatory requirements and minimize risks to users.

    Competitive Advantages

    Organizations that perform ISO 10993-16 testing can enjoy several competitive advantages:

  • Enhanced reputation

  • Regulatory compliance

  • Improved product safety

  • Cost savings through reduced recalls and liabilities

    • Cost-Benefit Analysis

    The cost-benefit analysis of performing ISO 10993-16 testing is favorable, as the benefits far outweigh the costs.

    ---

    Why This Specific Test is Needed and Required

    ISO 10993-16 testing is essential for organizations that develop and market medical devices. This test evaluates the toxicokinetic properties of materials used in medical devices to ensure they meet regulatory requirements and minimize risks to users.

    Business and Technical Reasons for Conducting ISO 10993-16 Testing

    Organizations conduct ISO 10993-16 testing due to:

  • Regulatory compliance

  • Risk management

  • Quality assurance

  • Improved product safety

    • Consequences of Not Performing This Test

    Failure to perform ISO 10993-16 testing can result in:

  • Regulatory non-compliance

  • Product recalls

  • Damage to reputation

  • Increased costs through liabilities and recalls

    • Industries and Sectors that Require This Testing

    The following industries and sectors require ISO 10993-16 testing:

  • Medical device manufacturers

  • Biotechnology companies

  • Pharmaceutical industry

  • Research institutions

    • These organizations must ensure their products meet the necessary safety and performance requirements.

    Quality Assurance and Quality Control Measures

    Organizations implementing quality assurance and quality control measures can ensure the accuracy and reliability of test results. This includes:

  • Use of standardized testing protocols

  • Regular calibration and maintenance of equipment

  • Training of personnel

    • ---

    A toxicokinetic study protocol is a comprehensive plan for evaluating the toxicokinetic properties of materials used in medical devices. The purpose of this test is to determine the potential risks associated with exposure to these materials.

    Study Design and Protocol

    The study design and protocol must be carefully planned and executed to ensure accurate results. This includes:

  • Selection of testing parameters

  • Determination of sample size

  • Use of standardized testing protocols

    • Data Analysis and Interpretation

    Data analysis and interpretation are critical components of toxicokinetic study protocols. This includes:

  • Statistical analysis of data

  • Identification of potential hazards

  • Development of mitigation strategies

    • ---

    Toxicokinetics and toxicodynamics are essential components of toxicological evaluation.

    Toxicokinetics

    Toxicokinetics refers to the processes by which a substance is absorbed, distributed, metabolized, and excreted. This includes:

  • Absorption

  • Distribution

  • Metabolism

  • Excretion

    • Toxicodynamics

    Toxicodynamics refers to the interactions between a substance and biological systems. This includes:

  • Binding to receptors

  • Activation of cellular pathways

  • Induction of toxicity

    • ---

    The ISO 10993-16 testing procedure involves several steps, including:

    1. Selection of testing parameters

    2. Determination of sample size

    3. Use of standardized testing protocols

    4. Data analysis and interpretation

    5. Reporting of results

    Selection of Testing Parameters

    The selection of testing parameters is critical to ensure accurate results. This includes:

  • Choice of testing methods

  • Selection of testing materials

  • Determination of testing duration

    • Determination of Sample Size

    The determination of sample size is essential to ensure statistical validity of the test results.

    Use of Standardized Testing Protocols

    Standardized testing protocols ensure consistency and reliability of test results. This includes:

  • Use of ISO 10993-1:2018

  • Use of ASTM F1980-14

    • ---

    Data analysis and interpretation are critical components of toxicokinetic study protocols.

    Statistical Analysis of Data

    Statistical analysis of data is essential to ensure accurate results. This includes:

  • Descriptive statistics

  • Inferential statistics

  • Hypothesis testing

    • Identification of Potential Hazards

    The identification of potential hazards is critical to develop mitigation strategies.

    Development of Mitigation Strategies

    Mitigation strategies aim to minimize risks associated with exposure to materials used in medical devices.

    ---

    Reporting of results is essential to ensure accurate communication of test findings. This includes:

  • Reporting of positive and negative results

  • Identification of potential hazards

  • Development of mitigation strategies

    • Conclusion

    ISO 10993-16 testing is a critical component of toxicological evaluation. It ensures that materials used in medical devices meet regulatory requirements and minimize risks to users.

    ---

    The implementation and maintenance of ISO 10993-16 testing protocols are essential for organizations that develop and market medical devices.

    Implementation

    Implementation involves several steps, including:

  • Development of a quality management system

  • Selection of testing parameters

  • Determination of sample size

  • Use of standardized testing protocols

    • Maintenance

    Maintenance involves regular review and update of test protocols to ensure they remain relevant and effective. This includes:

  • Regular calibration and maintenance of equipment

  • Training of personnel

  • Review of regulatory requirements

    • Need help or have a question?
    Contact us for prompt assistance and solutions.

    CONTACT US +902127020000

    Latest News

    View all

    Eurolab Successfully Renews ISO 17025 Accreditation

    Read More

    Expanded Cosmetic Safety Testing Portfolio Now Available at Eurolab

    Read More

    Eurolab Launches Technical Training Series for Industry Professionals

    Read More

    JOIN US
    Want to make a difference?

    Careers